Role of CTR4 in the virulence of cryptococcus neoformans

mBio

Volumn 3, Issue 5, 2012, Pages

  Waterman, Scott R ^a,b   Park, y D ^a,b   Raja, Meera ^c   Qiu, Jin ^a,b   Hammoud, Dima A ^d   O'Halloran, Thomas V ^c   Williamson, Peter R ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868384233     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00285-12     Document Type: Article

References (47)

1. Park BJ, et al. 2009. Estimation of the current global burden of crypto-coccal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
2. Olszewski MA, Zhang Y, Huffnagle GB. 2010. Mechanisms of crypto-coccal virulence and persistence. Future Microbiol. 5:1269-1288.
3. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:4225-4237.
4. Van Ho A, Ward DM, Kaplan J. 2002. Transition metal transport in yeast. Annu. Rev. Microbiol. 56:237-261.
5. Koch KA, Peña MM, Thiele DJ. 1997. Copper-binding motifs in catalysis, transport, detoxification and signaling. Chem. Biol. 4:549-560.
6. Labbé S, Thiele DJ. 1999. Pipes and wiring: the regulation of copper uptake and distribution in yeast. Trends Microbiol. 7:500-505.
7. O'Halloran TV, Culotta VC. 2000. Metallochaperones, an intracellular shuttle service for metal ions. J. Biol. Chem. 275:25057-25060.
8. Schaible UE, Kaufmann SH. 2004. Iron and microbial infection. Nat. Rev. Microbiol. 2:946-953.
9. Cox GM, et al. 2003. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect. Immun. 71:173-180.
10. Salas SD, Bennett JE, Kwon-Chung KJ, Perfect JR, Williamson PR. 1996. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med. 184:377-386.
11. Walton FJ, Idnurm A, Heitman J. 2005. Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans. Mol. Microbiol. 57:1381-1396.
12. Toffaletti DL, Del Poeta M, Rude TH, Dietrich F, Perfect JR. 2003. Regulationof cytochrome coxidase subunit1 (COX1) expression inCryp-tococcus neoformans by temperature and host environment. Microbiology 149:1041-1049.
13. Erickson T, et al. 2001. Multiple virulence factors of Cryptococcus neofor-mans are dependent on VPH1. Mol. Microbiol. 42:1121-1131.
14. Zhu X, Williamson PR. 2003. A CLC-type chloride channel gene is required for laccase activity and virulence in Cryptococcus neoformans. Mol. Microbiol. 50:1271-1281.
15. Jung WH, et al. 2008. Iron source preference and regulation of iron uptake in Cryptococcus neoformans. PLoS Pathog. 4: e45.
16. Sedlák E, Ziegler L, Kosman DJ, Wittung-Stafshede P. 2008. In vitro unfolding of yeast multicopper oxidase Fet3p variants reveals unique role of each metal site. Proc. Natl. Acad. Sci. U. S. A. 105:19258-19263.
17. Silva FD, et al. 2011. Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans. FEMS Microbiol. Lett. 324:64-72.
18. Waterman SR, et al. 2007. Role of a CUF1-CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J. Clin. Invest. 117:794-802.
19. Ding C, et al. 2011. The copper regulon of the human fungal pathogen Cryptococcus neoformans H99. Mol. Microbiol. 81:1560-1576.
20. Chun CD, Madhani HD. 2010. Ctr2 links copper homeostasis to poly-saccharide capsule formation and phagocytosis inhibition in the human fungal pathogen Cryptococcus neoformans. PLoS One 5: e12503.
21. Ory JJ, Griffith CL, Doering TL. 2004. An efficiently regulated promoter system for Cryptococcus neoformans utilizing the CTR4 promoter. Yeast 21:919-926.
22. Williamson PR. 1994. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176:656-664.
23. Waterman SR, et al. 2007. Cell wall targeting of laccase of Cryptococcus neoformans during infection of mice. Infect. Immun. 75:714-722.
24. Littman ML. 1958. Capsule synthesis by Cryptococcus neoformans. Trans. N. Y. Acad. Sci. 20:623-648.
25. Varma A, et al. 2006. Identification of a novel gene, URE2, that functionally complements a urease-negative clinical strain of Cryptococcus neofor-mans. Microbiology 152:3723-3731.
26. Chang YC, Kwon-Chung KJ. 1994. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919.
27. Garcia-Hermoso D, Dromer F, Janbon G. 2004. Cryptococcus neofor-mans capsule structure evolution in vitro and during murine infection. Infect. Immun. 72:3359-3365.
28. Moyrand F, Klaproth B, Himmelreich U, Dromer F, Janbon G. 2002. Isolation and characterizationof capsule structure mutant strains ofCryp-tococcus neoformans. Mol. Microbiol. 45:837-849.
29. McClelland EE, Perrine WT, Potts WK, Casadevall A. 2005. Relationship ofvirulence factor expression toevolved virulenceinmouse-passaged Cryptococcus neoformans lines. Infect. Immun. 73:7047-7050.
30. Fan W, Kraus PR, Boily MJ, Heitman J. 2005. Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot. Cell 4:1420-1433.
31. Hu G, et al. 2008. PI3K signaling of autophagy is required for starvation tolerance and virulence of Cryptococcus neoformans. J. Clin. Invest. 118: 1186-1197.
32. Zhu X, Gibbon J, Zhang S, Williamson P. 2002. Copper-mediated reversal of defective laccase in a vph1 avirulent mutant of Cryptococcus neoformans. Mol. Microbiol. 47:1007-1014.
33. Bhaumik S, DePuy J, Klimash J. 2007. Strategies to minimize background autofluorescence in live mice during noninvasive fluorescence optical imaging. Lab. Anim. (NY) 36:40-43.
34. Klionsky DJ, et al. 2008. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4:151-175.
35. Wolschendorf F, et al. 2011. Copper resistance is essential for virulence of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 108:1621-1626.
36. Price MS, et al. 2011. Cryptococcus neoformans requires a functional glycolytic pathway for disease but not persistence in the host. mBio 2(3): e00103-e00111.
37. Lee A, et al. 2010. Survival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitis. Infect. Immun. 78:4213-4225.
38. Zhou H, Thiele DJ. 2001. Identification of a novel high affinity copper transport complex in the fission yeast Schizosaccharomyces pombe. J. Biol. Chem. 276:20529-20535.
39. Ioannoni R, Beaudoin J, Mercier A, Labbé S. 2010. Copper-dependent trafficking of the Ctr4-Ctr5 copper transporting complex. PLoS One 5: e11964.
40. Wagner D, et al. 2005. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system. J. Immunol. 174:1491-1500.
41. Varma A, Edman JC, Kwon-Chung KJ. 1992. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect. Im-mun. 60:1101-1108.
42. McDade HC, Cox GM. 2001. A new dominant selectable marker for use in Cryptococcus neoformans. Med. Mycol. 39:151-154.
43. Liu X, Hu G, Panepinto J, Williamson PR. 2006. Role of a VPS41 homologue in starvation response, intracellular survival and virulence of Cryptococcus neoformans. Mol. Microbiol. 61:1132-1146.
44. Oliveira DL, et al. 2010. Extracellular vesicles from Cryptococcus neofor-mans modulate macrophage functions. Infect. Immun. 78:1601-1609.
45. Levitz SM, DiBenedetto DJ, Diamond RD. 1987. A rapid fluorescent assay to distinguish attached from phagocytized yeast particles. J. Immunol. Methods 101:37-42.
46. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR. 2000. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68: 443-448.
47. Liu L, Tewari RP, Williamson PR. 1999. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect. Im-mun. 67:6034-6039.